Resolutions by Lassila & Tikanoja plc’s Annual General

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Resolutions by Lassila & Tikanoja plc’s Annual General Meeting

Helsinki, Finland, 2014-03-19 16:30 CET (GLOBE NEWSWIRE) -- Lassila & Tikanoja plc                Stock exchange release          19 March 2014 5.30 pm

The Annual General Meeting of Lassila & Tikanoja plc, which was held today on 19 March 2014, adopted the financial statements and consolidated financial statements for the financial year 2013 and discharged the members of the Board of Directors and the President and CEO from liability. The Annual General Meeting resolved on the use of the profit shown on the balance sheet and the payment of dividend, the composition and remuneration of the Board of Directors, the election of the Auditor and on the authorisation of the Board of Directors to repurchase the company's shares and to decide on the share issue and the issuance of special rights entitling to shares.

Resolution on the use of the profit shown on the balance sheet and the payment of dividend

The Annual General Meeting resolved that a dividend of EUR 0.50 per share be paid on the basis of the balance sheet to be adopted for the financial year 2013. The dividend will be paid to a shareholder who is registered in the Company’s shareholders’ register maintained by Euroclear Finland Ltd on the record date for dividend payment, 24 March 2014. The dividend will be paid on 31 March 2014.

Composition and remuneration of the Board of Directors

The number of the members of the Board of Directors was confirmed six (6). The following Board members were re-elected to the Board until the end of the following AGM: Heikki Bergholm, Eero Hautaniemi, Hille Korhonen, Sakari Lassila and Miikka Maijala. Ms. Laura Lares was elected as a new member of the Board of Directors.

The Annual General Meeting resolved on the following annual fees: Chairman EUR 46,250, Vice Chairman EUR 30,500 and the ordinary members EUR 25,750.

The fees shall be paid so that 40% of the annual fee is paid in Lassila & Tikanoja's shares held by the company or, if this is not feasible, shares acquired from the markets, and 60% in cash. Shares are to be issued to Board members and, where necessary, acquired directly from the markets on behalf of Board members within the next fourteen trading days, free from restrictions on trading, from the Annual General Meeting. In addition, the following meeting fees will be paid: Chairman EUR 1,000, Vice Chairman EUR 700 and members EUR 500 per meeting. The meeting fees will also be paid to the Chairman and to the members of the committees established by the Board as follows: Chairman EUR 700 and members EUR 500.

Auditor

The Annual General Meeting re-elected KPMG Oy Ab Authorised Public Accountants, as Auditor of the Company until the close of the next Annual General Meeting. KPMG Oy Ab has announced that it will name Lasse Holopainen, Authorised Public Accountant, as its principal auditor. The meeting resolved that the fees of the Auditor will be paid according to invoice presented.

Authorising the Board of Directors to decide on the repurchase of the Company’s own shares

The Annual General Meeting authorised the Board of Directors to repurchase Company shares under the following terms and conditions:

By virtue of the authorisation, the Board of Directors is authorised to repurchase a maximum of 2,000,000 Company’s own shares using the Company’s non-restricted equity. This number of shares corresponds to approximately 5.2 % of the Company’s total number of shares on the date of the notice to the meeting.

The Company’s own shares will be repurchased otherwise than in proportion to the existing shareholdings of the Company’s shareholders through trading on regulated market organized by NASDAQ OMX Helsinki Ltd (“Stock Exchange”) at the market price quoted at the time of the repurchase. Shares will be acquired and paid for in accordance with the rules of the Stock Exchange and Euroclear Finland Ltd.

The purpose of the share repurchase is to develop the Company’s capital structure and/or to use the shares as consideration in potential acquisitions, other business arrangements, as part of the Company’s share-based incentive programme, or to finance investments. The repurchased shares may either be held by the Company, or cancelled or conveyed.

The Board of Directors shall decide on other terms and conditions related to the share repurchase. The share repurchase authorisation shall be valid for 18 months.

Authorising the Board of Directors to decide on the share issue and the issuance of special rights entitling to shares

The Annual General Meeting authorised the Board of Directors to decide, in one or more instalments, on issuance of new shares or shares possibly held by the Company through share issue and/or issuance of option rights or other special rights entitling to shares, referred to in Chapter 10, Section 1 of the Finnish Companies Act, so that by virtue of the authorisation altogether 2,000,000 shares may be issued and/or conveyed at the maximum. This number of shares corresponds to approximately 5.2 % of the Company’s total number of shares on the date of the notice to the meeting.

It is proposed that the authorisation be used for the financing or execution of potential acquisitions or other arrangements or investments relating to the Company’s business, for the implementation of the Company’s incentive scheme or for other purposes subject to the Board of Directors’ decision.

It is proposed that the authorisation entitles the Board of Directors to decide on all terms and conditions of the share issue and the issuance of special rights referred to in Chapter 10, Section 1 of the Finnish Companies Act. The authorisation thus includes the right to issue shares also in a proportion other than that of the shareholders’ current shareholdings in the Company under the conditions provided in law, the right to issue shares against payment or without charge as well as the right to decide on a share issue without payment to the Company itself, subject to the provisions of the Finnish Companies Act on the maximum amount of treasury shares.

It is proposed that the authorisation would be valid for 18 months.

The minutes of the meeting will be available on the company website www.lassila-tikanoja.com as from 2 April 2014 at the latest.

LASSILA & TIKANOJA PLC

Pekka Ojanpää President and CEO

For additional information, please contact Timo Leinonen, CFO, tel. +358 400 793 073.

Lassila & Tikanoja is a service company that is transforming the consumer society into an efficient recycling society. In co-operation with our customers we are reducing waste volumes, extending the useful lives of properties, recovering materials and decreasing the use of raw materials and energy. We help our customers to focus on their core business and to save the environment. Together, we create well-being and jobs. With operations in Finland, Sweden and Russia, L&T employs 8,000 persons. Net sales in 2013 amounted to EUR 668.2 million. L&T is listed on NASDAQ OMX Helsinki.

Distribution: NASDAQ OMX Helsinki Major media www.lassila-tikanoja.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Centrus Energy's Quarter Ups and Downs Unpacked

Updated Category News Views 19

Stirring the Pot: Centrus Energy's Rollercoaster Quarter Trading never fails to serve up surprises, and Centrus Energy Corp. (NYSE:LEU) is dishing them out this quarter. Despite a revenue slip to $55.5 million from last year’s $74.9 million, GAAP net income rocketed to a whopping $31.6 million. Talk about a mixed bag of fortunes. Diving Deeper into the Numbers Revenue...

Continue Reading
Gates Unveils Poly Chain® Carbon™: A Game Changer?

Updated Category News Views 24

Rethinking Industrial Chains with Poly Chain® Carbon ONE Amid today's relentless industrial landscape, Gates Industrial Corporation is stepping into the spotlight by debuting the Poly Chain® Carbon™ ONE. This ain't just another product release—it's a full-throttle attempt to shake up the heavy-duty power transmission industry. Stakeholders, take note: this launch...

Continue Reading
MY DR NOW Expands: Seven-Day Clinics Open Everywhere

Updated Category News Views 48

Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...

Continue Reading
Belay Diagnostics Clinches Second Palantir Title

Updated Category News Views 45

Innovation in Liquid Biopsy Lands Belay Another Win Another round of applause is due for Belay Diagnostics, the brainy bunch in molecular diagnostics focused on CSF liquid biopsy for CNS cancers. This Chicago-based powerhouse clinched its second consecutive victory at the Palantir Foundry Buildcamp competition. The team must be on some winning streak, as they're not just...

Continue Reading
Life with PAH: A Journey of Awareness and Hope

Updated Category News Views 230

Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...

Continue Reading
Menarini & Ryvu's Phase II Results Offer Hope in B-NHL

Updated Category News Views 113

New Glimmers of Hope in B-cell NHL Battle Battling aggressive B-cell non-Hodgkin lymphoma (B-NHL) isn't for the faint of heart, especially when standard treatments have been run through like an old pair of boots. Enter dapolsertib, the fresh-faced newcomer in Menarini Group and Ryvu Therapeutics' arsenal, showing encouraging signals in early Phase II results. These...

Continue Reading
Peabody's Q3 2026: Margins Climb Despite Net Loss

Updated Category News Views 26

Tough Quarters but Promising Margins Alright, Peabody's Q3 2026 isn't the most sunshine-filled report I've laid eyes on, but it's not all shadows either. Sure, they posted a net loss of $32.8 million, better than last year's $70.1 million drain. Admit it or not, that's improvement. And yet, the real gem here is those expanding margins gleaming despite the loss-heavy...

Continue Reading
Kaolin Market Surges to $8.89B by 2031: Key Trends

Updated Category News Views 113

Riding the Kaolin Wave: Industrial Market Expansion You can't miss the sound of kaolin clinking in as it rides the tide of industrial demand. Reports from MarketsandMarkets™ have kaolin's party rocking all the way to a hefty $8.89 billion by 2031, up from $6.19 billion in 2026. With a sensible 7.5% compound annual growth rate (CAGR), this clay’s is aiming for the...

Continue Reading
P.C. Richard & Son's Generations+: Loyalty Rewarded

Updated Category News Views 60

What's the Deal with Generations+ at P.C. Richard & Son? Felt like companies were giving away the farm just to keep customers hooked, and then I heard about P.C. Richard & Son's latest play. They've been around for a scorching 117 years, and now they're offering something they've never done before: a free membership program called Generations+ that tosses perks like candy...

Continue Reading
AlphaESS Stretches Influence with Adriatic Energy Boost

Updated Category News Views 103

AlphaESS Charges into the Adriatic Region Kicking off with a bang in Zagreb, AlphaESS didn't just show up at the Green Energy Fair 2026—they turned the spotlights on their expanding role across the Adriatic region. This ain't your run-of-the-mill industry showcase. They've been busy throwing up energy storage units like they're growing crops. With a strong lineup...

Continue Reading

Top 5 Most Recently Viewed Articles

LXP Industrial Trust Sets Date for Fourth Quarter Results Call

Updated Category News Views 131

LXP Industrial Trust Announces Financial Results Call LXP Industrial Trust (NYSE: LXP), a prominent real estate investment trust (REIT), specializes in high-quality warehouse and distribution properties. Based in West Palm Beach, Florida, the company is gearing up to share its financial performance for the fourth quarter of 2024. The announcement was made recently,...

Continue Reading
ConocoPhillips Aims to Maintain Creditor Priority in Citgo Auction

Updated Category News Views 169

ConocoPhillips Takes Action in Citgo Share Auction ConocoPhillips (NYSE: COP) is actively working to ensure its position as a top creditor in the auction of Citgo Petroleum shares. This auction aims to generate cash for Venezuela's outstanding foreign debts, with Citgo being the sole asset of PDV Holding, which a U.S. court has determined is liable for these debts....

Continue Reading
Cheniere Energy's Strong Q2 Performance Forecasts Future Growth

Updated Category News Views 188

Cheniere Energy's Strong Q2 Performance Recent results from Cheniere Energy (NYSE: LNG) have indicated a promising trend for investors and traders alike. The performance in the second quarter has not only confirmed bullish forecasts but also highlighted the terms of growing LNG demand driven by new infrastructure. This trend is enhanced by the increasing demand for...

Continue Reading
AI Adoption Insights: Trends, Challenges, and Future Innovations

Updated Category News Views 102

AI Adoption Insights: Trends and Strategies for Business Leaders In an era where technology is rapidly evolving, understanding the state of AI adoption among business leaders is more important than ever. A recent survey conducted by HumanX, the premier conference for artificial intelligence leaders, in collaboration with HarrisX, sheds light on key trends, opportunities,...

Continue Reading
Growth Drivers in the Surgical Gowns and Drapes Market

Updated Category News Views 160

Surgical Gowns and Drapes Market Overview The surgical gowns and drapes market is poised for remarkable growth, with projections showing an increase from around USD 4.69 billion in 2025 to an anticipated USD 6.01 billion by 2030. A compound annual growth rate (CAGR) of approximately 5.1% reflects the rising demand for protective apparel in surgical settings. Effective...

Continue Reading